Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
celgene
3
×
biotech
bristol-myers squibb
deals
life sciences
national blog main
acquisition
acquisitions
autoimmune diseases
bay city capital
biogen
clinical trials
coronavirus
covid-19
crohn's disease
drug development
europe blog main
europe top stories
fda
fibrosis
fingolimod
ftc
galecto
health/life sciences
interferon-beta
juno therapeutics
m&a
merger
mergers and acquisitions
multiple sclerosis
national top stories
new york
new york blog main
new york top stories
novartis
ozanimod
pharmakea
psoriasis
regulators
rob williamson
What
bristol
celgene
3
×
drug
3
×
myers
3
×
squibb
acquisition
acquire
amid
amira
approved
approves
billion
biotech
came
candidate
company’s
concerns
confidence
deal
delay
delayed
divest
expect
fda
fibrotic
ftc
galecto
group
investors
juno
launch
major
merger
ms
multiple
new
news
pandemic
parent
pharmaceuticals
Language
unset
Current search:
myers
×
celgene
×
drug
×
celgene
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}